MGLL and prostate cancer: In a follow-up study with prostate cancer cells, inhibition of cancer cell migration after MAGL inhibition by JZL184 or MAGL shRNA was partially reversed by the addition of fatty acids or CB1 receptor antagonists and completely reversed by the combination of both substances [125].